Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Brain Stem Neoplasms × Mebendazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Astrocytoma 2 Optic Nerve Glioma 1 Oligodendroglioma 1 Medulloblastoma 1 Gliosarcoma 1 Brain Stem Neoplasms 1

Interventions

ovex 1 entinostat 1 azurin (50-77) 1 Thalidomide 1 Piperazine 1 Mebendazole 1 Irinotecan 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02644291 2022-06-23

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡